Poseida Therapeutics, Inc. — Form D

Poseida Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-04-22. The offering totals $150.0M, of which $142.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (37)

Showing 25 of 37 people.

NameRoleLocation
Noah BerkowitzRelated PersonSan Diego, CA
Mark GergenRelated PersonSan Diego, CA
David HirschRelated PersonSan Diego, CA
Marcea Bland LloydRelated PersonSan Diego, CA
Catherine J. MackeyRelated PersonSan Diego, CA
Sean MurphyRelated PersonSan Diego, CA
Eric OstertagRelated PersonSan Diego, CA
John SchmidRelated PersonSan Diego, CA
Matthew SpearRelated PersonSan Diego, CA
Brent J WarnerExecutive OfficerSAN DIEGO, CA
Robert LyonsDirectorGrand Cayman, E9
Mark GergenDirectorSan Diego, CA
Mark GergenExecutive OfficerSan Diego, CA
Charles M BaumDirectorBoston, MA
Harry J LeonhardtExecutive OfficerSan Diego, CA
Mark J GergenDirectorSan Diego, CA
Mark J GergenExecutive OfficerSan Diego, CA
Johanna M MyletExecutive OfficerSan Diego, CA
Luke M CorningDirectorSan Diego, CA
Cynthia M CollinsDirectorSan Diego, CA
Marcea B LloydDirectorSan Diego, CA
Kristin J YaremaExecutive OfficerSan Diego, CA
John B SchmidDirectorSan Diego, CA
Rafael J AmadoDirectorSan Diego, CA
David HirschDirectorSan Diego, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2023-08-11D$25.0M$25.0M
2018-04-03D$30.5M$30.5M
2017-08-03D$15.0M$11.2M
2015-12-24D$36.0M$23.0M

More